Swarm Oncology, a biotech developing novel T cell therapies to achieve long-term remission in patients with advanced solid ...

Despite these results, Novo Nordisk's stock experienced a downturn, which may reflect investor concerns over the commercial implications or regulatory prospects of the new dosage. The trial ...

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

Minnesota Attorney General Keith Ellison says his office has reached a settlement with Novo Nordisk over high insulin ...

Despite these results, Novo Nordisk's stock experienced a downturn, which may reflect investor concerns over the commercial implications or regulatory prospects of the new dosage. The trial outcomes ...

Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot ...

Health-care companies slipped, as traders rotated back into sectors more associated with artificial-intelligence developments. Novo Nordisk said the Food and Drug Administration approved the ...

On Friday, the Danish pharma giant released the stellar results from a phase 1/2 trial for a once-weekly jab in its pipeline.